Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Duncan Stearns, MD

Duncan Stearns, MD

  • Specialty: Pediatric Hematology and Oncology
    View Expertise
  • Primary Location: 11100 Euclid Ave (0 mi.)
    Other Locations
  • Languages Spoken: English

Office Locations

UH Rainbow Babies & Children's Hospital (0 mi.)

11100 Euclid Ave
8th Floor
Cleveland, OH 44106
216-844-1443

Biography: Duncan Stearns, MD

Expertise

  • Pediatric Brain Tumors
  • Pediatric Hematology
  • Pediatric Neuro-Oncology
  • Pediatric Oncology

Titles

  • Associate Professor, CWRU School of Medicine
  • Kimberly Vehovec Chair in Adolescent and Young Adult Cancer, UH Rainbow Babies & Children's Hospital

Certifications & Memberships

  • Pediatric Hematology-Oncology - American Board of Pediatrics

Education

Fellowship | Neuro-oncology
Neuro-oncology - Johns Hopkins Hospital (2003 - 2005)

Fellowship | Pediatric Hematology/Oncology
Pediatric Hematology/Oncology - Johns Hopkins Hospital (2000 - 2003)

Residency | Pediatrics
Pediatrics - Rhode Island Hospital (1997 - 2000)

Medical Education
University Of Pittsburgh School Of Medicine (1997)

Undergraduate
Harvard University (1987)

Featured Videos

Watch to find out more about this University Hospitals provider.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Duncan Stearns disclosed the following Outside Relationships with Industry:

  • - Pfizer, Inc. - Ownership
  • - Proctor and Gamble - Ownership